Two New Therapeutics Approved For Treating Multiple Myeloma
The flurry of decisions from the U.S. Food and Drug Administration (FDA) on investigational anticancer therapeutics continued last week...
Tag: Cancer immunotherapy
The flurry of decisions from the U.S. Food and Drug Administration (FDA) on investigational anticancer therapeutics continued last week...
Kimberly Stegmaier, MD, co-director of the pediatric hematologic malignancy program and associate professor of pediatrics at Dana-Farber Cancer Institute...
Levi Garraway, MD, PhD, co-chair of the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston Nov....
Earlier this week, the U.S. Food and Drug Administration (FDA) approved a first-of-its kind immunotherapeutic, talimogene laherparepvec or T-Vec...
The American Association for Cancer Research held two community events this week aimed at engaging the public in the...
Guest Post by Roswell Park Cancer Institute Department of Public Affairs
An emerging hallmark of cancer cells is their ability to hide from the body’s immune system. The human immune...
Late last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the...
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today
The number of anticancer immunotherapeutics approved by the U.S. Food and Drug Administration (FDA) is rising rapidly. In fact,...